SCRUTINIZER''S REPORT ON REMOTE E-VOTING AND E-VOTING.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals held an Extra-Ordinary General Meeting (EGM) on February 16, 2026, via video conferencing. The sole special resolution considered was the appointment of Mrs. Pooja Narendra Sanghavi (DIN: 11387388) as a Non-Executive Independent Director of the company. Out of 8,645 total shareholders, 57 members cast valid votes representing 1,037,035 shares (about 21.96% of outstanding shares). The resolution was passed unanimously with 100% votes in favour and zero votes against. Promoters voted 100% in favour with 1,036,460 shares, while public non-institutions contributed 575 votes, all in favour.
The appointment of a new Independent Director strengthens the board composition in line with corporate governance norms. With zero dissent, this is a routine but positive governance signal — no material impact on share price is expected.